Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: A meta-analysis

American Journal of Gastroenterology

Volumn 104, Issue 8, 2009, Pages 2089-2096

  Peyrin Biroulet, Laurent ^a   Deltenre, Pierre ^a,b   Ardizzone, Sandro ^c   D'Haens, Geert ^d   Hanauer, Stephen B ^e   Herfarth, Hans ^f   Lémann, Marc ^g   Colombel, Jean Frédéric ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Hospital de Jolimont   (Belgium)

^c UNIVERSITY OF MILAN   (Italy)

^d IMELDA HOSPITAL   (Belgium)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PLACEBO;

ABDOMINAL ABSCESS; ALOPECIA; ARTHRALGIA; ARTICLE; BONE MARROW TOXICITY; CLINICAL TRIAL; CROHN DISEASE; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FLATULENCE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HAIR LOSS; HUMAN; INTESTINE OBSTRUCTION; META ANALYSIS; PANCREATITIS; PARKINSON DISEASE; PHLEBITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; SENSITIVITY ANALYSIS; SIDE EFFECT; STOMACH DISEASE; SYSTEMATIC REVIEW;

EID: 68349137946     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.301     Document Type: Article

References (37)

1. Ng SC, Kamm MA. Management of postoperative Crohn's disease. Am J Gastroenterol 2008;103:1029-35.
2. Terdiman JP. Prevention of postoperative recurrence in Crohn's disease. Clin Gastroenterol Hepatol 2008;6:616-20.
3. Cosnes J, Nion-Larmurier I, Beaugerie L et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237-41.
4. Vernier-Massouille G, Balde M, Salleron J et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008;135:1106-13.
5. Schnitzler F, Fidder H, Ferrante M et al. Long-term outcome of treatment with infliximab in 61. Crohn's disease patients: results from a single centre cohort. Gut 2009;58:492-500.
6. D'Haens G, Baert F, van Assche G et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008;371:660-7.
7. Jess T, Riis L, Vind I et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007;13:481-9.
8. Sampietro GM, Corsi F, Maconi G et al. Prospective study of long-term results and prognostic factors after conservative surgery for small bowel Crohn's disease. Clin Gastroenterol Hepatol 2009;7:183-91.
9. Lemann M. Review article: can post-operative recurrence in Crohn's disease be prevented? Aliment Pharmacol Ther 2006; 24 (Suppl 3): 22-8.
10. Sandborn WJ, Feagan BG. The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain. Gastroenterology 2004;127:990-3.
11. Blum E, Katz JA. Postoperative therapy for Crohn's disease. Inflamm Bowel Dis 2008;15:463-72.
12. Caprilli R, Gassull MA, Escher JC et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006; 55 (Suppl 1): i36-58.
13. Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-63.
14. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 1992;33:331-5.
15. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000;231:38-45.
16. Rutgeerts P, Geboes K, Vantrappen G et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984;25:665-72.
17. Chardavoyne R, Flint GW, Pollack S et al. Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum 1986;29:495-502.
18. Camma C, Viscido A, Latella G et al. Mesalamine in the prevention of clinical and endoscopic postoperative recurrence of Crohn's disease: a meta-analysis. Dig Liv Dis 2002; 34. A86.
19. Caprilli R, Andreoli A, Capurso L et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colone del Retto (GISC). Aliment Pharmacol Ther 1994;8:35-43.
20. Lochs H, Mayer M, Fleig WE et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 2000;118:264-73.
21. Rutgeerts P, Van Assche G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005;128:856-61.
22. Hellers G, Cortot A, Jewell D et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999;116:294-300.
23. Marteau P, Lemann M, Seksik P et al. Ineff ectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006;55:842-7.
24. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996;17:1-12.
25. Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987;6:341-50.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
27. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
28. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:100-29.
29. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317:1309-12.
30. Ardizzone S, Maconi G, Sampietro GM et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004;127:730-40.
31. D'Haens GR, Vermeire S, Van Assche G et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008;135:1123-9.
32. Hanauer SB, Korelitz BI, Rutgeerts P et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004;127:723-9.
33. Herfarth H, Tjaden C, Lukas M et al. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. Gut 2006;55:1525-6.
34. Higgins JPT, Green S (Eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
35. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
36. Renna S, Camma C, Modesto I et al. Meta-analysis of placebo rates of clinical relapse and severe endoscopic recurrence in RCTs of operated Crohn's disease. Gastroenterology 2008;135:1500-9.
37. Pascua M, Su C, Lewis JD et al. Meta-analysis: factors predicting postoperative recurrence with placebo therapy in patients with Crohn's disease. Aliment Pharmacol Ther 2008;28:545-56.